High purity oritavancin and method of producing same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10328118
APP PUB NO 20170157206A1
SERIAL NO

15439206

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Drug substance preparations of oritavancin having high purity are disclosed, along with pharmaceutical compositions comprising such oritavancin drug substance preparations, and drug products or dosage forms comprising such pharmaceutical compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MELINTA THERAPEUTICS LLC389 INTERPACE PARKWAY SUITE 450 PARSIPPANY NJ 07054

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chemburkar, Sanjay R North Chicago, US 37 101
Ding, Min Irvington, US 81 1031
Knable, Carl M North Chicago, US 3 0
Krishna, Gopal Randolph, US 45 455
Petzel, James P North Chicago, US 3 0
Pruyne, Julie J North Chicago, US 8 2
Rafai, Far Adel Ville Saint Laurent, CA 13 27
Reamer, Douglas M North Chicago, US 4 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 25, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 25, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00